Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. - Wikidata - wikimedia - TriplyDB

Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.

Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.

http://www.wikidata.org/entity/Q34331911

about

A fourth IkappaB protein within the NF-kappaB signaling module Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases Regulation of Aicda expression and AID activity MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features Rescue of TRAF3-null mice by p100 NF-kappa B deficiency Elucidating the function of an ancient NF-kappaB p100 homologue, CrRelish, in antibacterial defense Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency.Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile The NF-κB genomic landscape in lymphoblastoid B cells.Circuitry of nuclear factor kappaB signaling.Alternative nuclear functions for NF-κB family members Protein kinase R is a novel mediator of CD40 signaling and plays a critical role in modulating immunoglobulin expression during respiratory syncytial virus infection Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.Activation of NF-kappaB by HTLV-I and implications for cell transformation.Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.Control of canonical NF-kappaB activation through the NIK-IKK complex pathway Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine.NF-kappa B as a therapeutic target in autoimmune disease.Antigen-mediated T cell expansion regulated by parallel pathways of death.TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy.NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia.NF-κB function in B lymphocytes.SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myeloma.Signaling mechanisms regulating B-lymphocyte activation and tolerance.Phytoconstituents as apoptosis inducing agents: strategy to combat cancer Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells.CD40L-mediated inhibition of NF-kappaB in CA46 Burkitt lymphoma cells promotes apoptosis.Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection.A membrane leucine heptad contributes to trafficking, signaling, and transformation by latent membrane protein 1.CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.

P2860

Q24676472-05304D1E-03D4-4E46-A96D-0497D78CFC05 Q24816875-645D7385-6837-47CA-A846-7305D500E095 Q26778328-48425450-BED5-4D3E-B722-3EFAE8D64D62 Q26853622-664630F3-9940-45CB-A189-2279E3874F4B Q28241703-390E8D9C-212C-4E2D-8C00-ABC8E1B5146D Q28303338-E64224DE-8C76-42D8-BB69-C35E451532B2 Q28506895-596B7A06-3F91-459C-AC17-037F70679881 Q28755808-42C7FA1F-0308-4806-AE86-8FB49AD3D8E7 Q33270518-33868D8E-736C-44D9-B603-72A8008192B9 Q33551720-329E1C06-DA39-4950-8F3E-BF5062B8CC43 Q34175522-65C3E339-EE1F-4AE3-9198-844E251EE1A0 Q34514908-1CE886C4-FD75-481E-9C71-96D2DC19F5B0 Q35263997-2975473C-B27E-4B7F-B3ED-82E86F208990 Q35598219-C715C5DC-CEE8-4F1C-A23D-EB0C07A805CA Q35815962-D45CD8B7-E864-4DF4-8D94-2912840C691D Q35848189-DD681C8E-F23D-4110-BA3A-0FDF1467C7B6 Q35919057-BC96B52A-D8EF-4C39-9A06-6D95219D1C28 Q36097312-CF5E7197-EAAB-4678-ACC0-3DA073570F2C Q36128542-2997233F-230F-4352-A405-35A17B2D3A2B Q36254865-B7DE7102-C4B7-48B7-9BED-3DBD7A990476 Q36384731-259D69CC-69A5-4720-9C45-0CE9865EC408 Q36403102-A747CEE2-5FFB-43F9-8FD2-431098656DC5 Q36491362-AB2E24EE-5748-4A25-B40B-D984E9A0EB89 Q36534234-ABC8C02D-B7C7-4BEC-986A-ADE92AFCD965 Q36569363-EF865781-9713-4B49-A94D-FAD996882F5B Q36688241-3A3EEBBD-7CE9-4C91-BC60-DE8948CB5011 Q36709522-2A02F100-2EF8-45CE-B290-B6F070049881 Q36970979-FB6B9DED-D0AC-41C3-A35B-130D68994ED9 Q37291416-0A4EE8A2-AD11-4017-8CDB-C21A2FE47B41 Q37564683-8D954F17-CB4E-49DD-92CC-449A2811A9DA Q37605861-750826F9-8DD5-41B6-A639-DC26D87AE4AD Q37995689-E65241E3-7456-4991-9BDB-6FE52A456AEF Q38065012-12F82D28-D4CE-46C5-908B-EFBC098494B2 Q38334794-C639A404-DBAC-4A9C-8FE2-6A7750CA592D Q38560204-E8E37233-6476-4B4C-A23F-9C9AFD54CE6A Q38798777-40269E15-9566-4EDE-B74A-70EC327CC74D Q39956735-9F5B1C44-B319-4967-8C30-5CECA6C31794 Q40035493-2642064D-7B7D-4F48-B555-35481DB17C54 Q40117245-C9B48C87-C8B5-45FE-8CF5-A8337BC162DC Q40143589-745602C0-A2E4-4136-BD31-1FE044DA60FD

P2860

Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.

http://www.wikidata.org/entity/Q34331911

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@ast

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@en

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@nl

type

label

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@ast

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@en

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@nl

prefLabel

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@ast

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@en

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@nl

P1433

Q34331911-35CA9AE8-37DC-4E81-810E-AF8B684D0010

P1476

Q34331911-93900740-48D1-44B9-8776-F07A20977067

P2093

Q34331911-021D89F6-3662-4B5F-8C87-76B23E6F45CC

Q34331911-3AFD8194-7161-47FD-A3C4-CAA844EC1838

Q34331911-4DD2732E-3BB8-4F39-9D69-E204C9BBD696

Q34331911-6AB3A2CF-7834-4EFE-8A39-844CDF0AA5DF

Q34331911-ECE7D8C5-43C3-434B-A474-7CED4B7D53B4

P2860

Q34331911-03569434-BA02-44BD-97F9-962DE5820B67

Q34331911-0582A85A-6212-4241-9EC0-A5DD07E47594

Q34331911-18616CEE-87E8-4585-8DA2-88C88588D5CE

Q34331911-1B445555-631A-4DDB-B19D-25D2309A03FC

Q34331911-1D56D7E4-419E-48C7-B2EA-EEFFBA5372CA

Q34331911-3FFC44A0-AE24-47A5-853A-36D725D73F02

Q34331911-549F7C9C-5682-4E71-AD62-38522951F97A

Q34331911-5C159343-7BF9-4407-8A3B-E1346C87854C

Q34331911-5D4DE8CF-25F6-4921-932A-0B53999B37F7

Q34331911-60AEBB22-D977-4007-B117-25154D404509

P304

Q34331911-200F376E-0551-4EC8-B2D8-BCF12E291108

P31

Q34331911-B852DF00-0346-454A-B46B-998482CD7024

P356

Q34331911-35828C54-0038-4617-BA9B-272EE1444C22

P407

Q34331911-3732397C-6EF9-4CAB-9B2C-645758CC25F8

P433

Q34331911-065DB3DF-5B72-48C3-AC3E-F90BD1ABE923

P478

Q34331911-615C6172-2C04-45AF-B380-BD6F59685900

P50

Q34331911-7B7B72DF-4A7B-46FE-A7D1-FEB8A2E19FC0

P577

Q34331911-DAA5943A-D8BA-4392-BE11-8F63325D8F03

P5875

Q34331911-96D52FD1-E12B-42F6-8FAA-F28A1B9F5E71

P698

Q34331911-9ED500CF-878C-46CC-B5D9-2B1EB0EF1504

P932

Q34331911-D4156D6D-B222-431D-B41C-AD197C36BEF2

P356

PNAS.0402629101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Unique CD40-mediated biologica ...... NF-kappaB activation pathways.

@en

P2093

Alexander Hoffmann

http://www.w3.org/2001/XMLSchema#string

Brian Zarnegar

http://www.w3.org/2001/XMLSchema#string

David Baltimore

http://www.w3.org/2001/XMLSchema#string

Gagik Oganesyan

http://www.w3.org/2001/XMLSchema#string

Jeannie Q He

http://www.w3.org/2001/XMLSchema#string

P2860

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells

Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation

NF-kappa B: ten years after

Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.

CD40-CD154 interactions in B-cell signaling.

P304

8108-8113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0402629101

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8558530

http://www.w3.org/2001/XMLSchema#string

P698

15148378

http://www.w3.org/2001/XMLSchema#string

P932

419565

http://www.w3.org/2001/XMLSchema#string